VAM
GILD icon

Verity Asset Management’s Gilead Sciences GILD Stock Holding History

Verity Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.45M Buy
10,432
+75
+0.7% +$10.5K 0.61% 54
2025
Q4 		$1.27M Sell
10,357
-10,237
-50% -$1.24M 0.55% 54
2025
Q3 		$2.29M Buy
20,594
+8,800
+75% +$1M 0.75% 32
2025
Q2 		$1.31M Sell
11,794
-12,446
-51% -$1.32M 0.62% 44
2025
Q1 		$2.72M Buy
24,240
+12,383
+104% +$1.28M 1.11% 18
2024
Q4 		$1.1M Buy
11,857
+997
+9% +$89.8K 0.62% 41
2024
Q3 		$911K Buy
10,860
+2,066
+23% +$158K 0.34% 80
2024
Q2 		$603K Buy
8,794
+123
+1% +$8.21K 0.24% 92
2024
Q1 		$635K Sell
8,671
-60
-0.7% -$4.61K 0.35% 73
2023
Q4 		$707K Buy
8,731
+168
+2% +$13.1K 0.45% 58
2023
Q3 		$642K Buy
8,563
+948
+12% +$72.9K 0.47% 61
2023
Q2 		$587K Sell
7,615
-109
-1% -$8.69K 0.44% 70
2023
Q1 		$641K Sell
7,724
-287
-4% -$23.8K 0.38% 79
2022
Q4 		$688K Sell
8,011
-4,384
-35% -$347K 0.59% 57
2022
Q3 		$765K Buy
+12,395
New +$782K 0.79% 41
2022
Q1 		$673K Buy
11,316
+3,904
+53% +$250K 0.43% 73
2021
Q4 		$538K Sell
7,412
-7,743
-51% -$533K 0.32% 96
2021
Q3 		$1.06M Buy
15,155
+247
+2% +$17.4K 0.69% 32
2021
Q2 		$1.03M Buy
14,908
+4,254
+40% +$284K 0.56% 39
2021
Q1 		$689K Buy
10,654
+2,208
+26% +$142K 0.41% 72
2020
Q4 		$492K Sell
8,446
-1,044
-11% -$63K 0.34% 80
2020
Q3 		$600K Buy
9,490
+2,553
+37% +$177K 0.46% 50
2020
Q2 		$500K Buy
6,937
+3,195
+85% +$245K 0.46% 55
2020
Q1 		$280K Buy
+3,742
New +$259K 0.35% 89
2015
Q4 		– Sell
-2,614
Closed -$257K – 82
2015
Q3 		$257K Buy
+2,614
New +$290K 0.26% 65

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Verity Asset Management's GILD Position: Q1 2026 in Review

Verity Asset Management increased its Gilead Sciences (GILD) stake by 0.72% in Q1 2026, buying an estimated $10.5K and bringing the position to 10,432 shares worth $1.45M. The position accounts for 0.61% of the portfolio, ranked #54.

Verity Asset Management first reported a position in GILD in Q3 2015 and has held it in 25 quarters since. The position peaked at $2.72M in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Verity Asset Management held 10,432 shares of Gilead Sciences worth $1.45M as of Q1 2026.
  • Verity Asset Management bought 75 Gilead Sciences shares in Q1 2026, an estimated $10.5K.
  • Gilead Sciences made up 0.61% of Verity Asset Management's portfolio in Q1 2026, its #54 holding.
  • Verity Asset Management first reported a position in Gilead Sciences in Q3 2015 and has held it in 25 quarters since.
  • Verity Asset Management's Gilead Sciences position peaked at $2.72M in Q1 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Verity Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.